Roland Liblau is a Professor of Clinical Immunology, and head of the Neuroimmunology team at the Toulouse Institute of Inflammatory and Infectious Diseases (INFINITY, UMR1291-CNRS 5051). He is heading a research laboratory of international reputation focusing on the etiology and effector mechanisms underlying inflammatory diseases of the central nervous system, including type 1 narcolepsy. He has published 240 articles referenced in PubMed (H-index: 6!).
